CAS NO: | 1255639-43-0 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | CMC2.24 (TRB-N0224), an orally active tricarbonylmethane agent, is effective against pancreatic tumor in mice by inhibitingRasactivation and its downstream effector ERK1/2 pathway. CMC2.24 is also a potent inhibitor of zinc-dependentMMPswith IC50s ranging from 2.0-69 μM. CMC2.24 alleviates osteoarthritis progression by restoring cartilage homeostasis and inhibiting chondrocyteapoptosisvia the NF-κB/HIF-2α axis[1][2][3]. | ||||||||||
IC50& Target[1][3] |
| ||||||||||
体外研究 (In Vitro) | CMC2.24 (0-60 μM; 24 hours) inhibits pancreatic cancer growth in vitro[1]. Cell Viability Assay[1]
| ||||||||||
体内研究 (In Vivo) | CMC2.24 (50 mg/kg; p.o.; five times per week during 17 days) inhibits the growth of pancreatic cancer xenografts[1].
| ||||||||||
分子量 | 427.45 | ||||||||||
性状 | Solid | ||||||||||
Formula | C26H21NO5 | ||||||||||
CAS 号 | 1255639-43-0 | ||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||
储存方式 | -20°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||
溶解性数据 | In Vitro: DMSO :< 1 mg/mL(insoluble or slightly soluble) |